{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:07:47Z","timestamp":1785859667010,"version":"3.56.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The incidence of gastric cancer among younger patients is increasing globally, with growing attention being paid to the role of homologous recombination deficiency (HRD). However, the effect of HRD on treatment outcomes and prognosis in this population remains unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed clinical and genomic data from the Center for Cancer Genomics and Advanced Therapeutics database. Younger patients (\u2264\u200939\u00a0years, <jats:italic>n<\/jats:italic>\u2009=\u2009140) were compared with older patients (\u2265\u200965\u00a0years, <jats:italic>n<\/jats:italic>\u2009=\u20091118) diagnosed with gastric cancer. This study focused on mutations in homologous recombination repair (HRR) genes and their association with tumor mutation burden (TMB), microsatellite instability (MSI), and treatment outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In older patients, HRD was associated with higher TMB and microsatellite instability-high (MSI-H) status, whereas no such correlations were observed in younger patients. Notably, MSI-H status was not observed in the younger group. Younger patients with HRD had a significantly shorter time to treatment failure (TTF) and overall survival (OS) than those without HRD. Conversely, in older patients, there was no significant difference in TTF or OS based on HRD status.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>HRR gene mutations influence genomic profiling, TMB, and MSI differently depending on the age of gastric cancer onset, suggesting potential effects on treatment efficacy and prognosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00535-025-02267-3","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T13:48:33Z","timestamp":1749822513000},"page":"1232-1241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Distinct age-related effects of homologous recombination deficiency on genomic profiling and treatment efficacy in gastric cancer"],"prefix":"10.1007","volume":"60","author":[{"given":"Yoshie","family":"Maki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-5196","authenticated-orcid":false,"given":"Yoshiyasu","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Ozato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hirasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ennishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuta","family":"Tomida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Iwamuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyuki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"2267_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.20892\/j.issn.2095-3941.2024.0159","volume":"21","author":"N Tan","year":"2024","unstructured":"Tan N, Wu H, Cao M, et al. Global, regional, and national burden of early-onset gastric cancer. Cancer Biol Med. 2024;21:667\u201378. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0159.","journal-title":"Cancer Biol Med"},{"key":"2267_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00535-018-1525-4","volume":"54","author":"Y Kono","year":"2019","unstructured":"Kono Y, Kanzaki H, Tsuzuki T, et al. A multicenter observational study on the clinicopathological features of gastric cancer in young patients. J Gastroenterol. 2019;54:419\u201326. https:\/\/doi.org\/10.1007\/s00535-018-1525-4.","journal-title":"J Gastroenterol"},{"key":"2267_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJMoa2211807","volume":"388","author":"Y Usui","year":"2023","unstructured":"Usui Y, Taniyama Y, Endo M, et al. Helicobacter pylori, homologous-recombination genes, and gastric cancer. N Engl J Med. 2023;388:1181\u201390. https:\/\/doi.org\/10.1056\/NEJMoa2211807.","journal-title":"N Engl J Med"},{"key":"2267_CR4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/jmg-2022-108816","volume":"60","author":"C Zhang","year":"2023","unstructured":"Zhang C, Zhu D, Qu Y, et al. Profiling of the genetic features of Chinese patients with gastric cancer with HRD germline mutations in a large-scale retrospective study. J Med Genet. 2023;60:760\u20138. https:\/\/doi.org\/10.1136\/jmg-2022-108816.","journal-title":"J Med Genet"},{"key":"2267_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/hep.32812","volume":"78","author":"J An","year":"2023","unstructured":"An J, Oh JH, Oh B, et al. Clinicogenomic characteristics and synthetic lethal implications of germline homologous recombination-deficient hepatocellular carcinoma. Hepatology. 2023;78:452\u201367. https:\/\/doi.org\/10.1002\/hep.32812.","journal-title":"Hepatology"},{"key":"2267_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235608","author":"M Ito","year":"2023","unstructured":"Ito M, Kubo M, Kawaji H, et al. Homologous recombination repair gene alterations are associated with tumor mutational burden and survival of immunotherapy. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15235608.","journal-title":"Cancers (Basel)."},{"key":"2267_CR7","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s00432-021-03781-6","volume":"148","author":"H Kim","year":"2022","unstructured":"Kim H, Ahn S, Hong JY, et al. The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors. J Cancer Res Clin Oncol. 2022;148:2427\u201335. https:\/\/doi.org\/10.1007\/s00432-021-03781-6.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2267_CR8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1158\/1078-0432.ccr-13-2287","volume":"20","author":"KP Pennington","year":"2014","unstructured":"Pennington KP, Walsh T, Harrell MI, et al. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res. 2014;20:764\u201375. https:\/\/doi.org\/10.1158\/1078-0432.ccr-13-2287.","journal-title":"Clin Cancer Res"},{"key":"2267_CR9","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/annonc\/mdq577","volume":"22","author":"DJ Gallagher","year":"2011","unstructured":"Gallagher DJ, Konner JA, Bell-McGuinn KM, et al. Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Ann Oncol. 2011;22:1127\u201332. https:\/\/doi.org\/10.1093\/annonc\/mdq577.","journal-title":"Ann Oncol"},{"key":"2267_CR10","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1158\/2159-8290.cd-22-0417","volume":"12","author":"T Kohno","year":"2022","unstructured":"Kohno T, Kato M, Kohsaka S, et al. C-CAT: The National datacenter for cancer genomic medicine in Japan. Cancer Discov. 2022;12:2509\u201315. https:\/\/doi.org\/10.1158\/2159-8290.cd-22-0417.","journal-title":"Cancer Discov"},{"key":"2267_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-024-02173-0","author":"K Ishigaki","year":"2024","unstructured":"Ishigaki K, Tokito Y, Takahara N, et al. Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database. J Gastroenterol. 2024. https:\/\/doi.org\/10.1007\/s00535-024-02173-0.","journal-title":"J Gastroenterol"},{"key":"2267_CR12","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s10120-024-01542-1","volume":"27","author":"H Ichikawa","year":"2024","unstructured":"Ichikawa H, Aizawa M, Kano Y, et al. Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy. Gastric Cancer. 2024;27:1273\u201386. https:\/\/doi.org\/10.1007\/s10120-024-01542-1.","journal-title":"Gastric Cancer"},{"key":"2267_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.708294","volume":"11","author":"J Dai","year":"2021","unstructured":"Dai J, Jiang M, He K, et al. DNA damage response and repair gene alterations increase tumor mutational burden and promote poor prognosis of advanced lung cancer. Front Oncol. 2021;11: 708294. https:\/\/doi.org\/10.3389\/fonc.2021.708294.","journal-title":"Front Oncol"},{"key":"2267_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/1535-7163.mct-20-0879","volume":"21","author":"M Cerniglia","year":"2022","unstructured":"Cerniglia M, Xiu J, Grothey A, et al. Association of homologous recombination-DNA damage response gene mutations with immune biomarkers in gastroesophageal cancers. Mol Cancer Ther. 2022;21:227\u201336. https:\/\/doi.org\/10.1158\/1535-7163.mct-20-0879.","journal-title":"Mol Cancer Ther"},{"key":"2267_CR15","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.21037\/tlcr-20-1130","volume":"9","author":"Y Xu","year":"2020","unstructured":"Xu Y, Li H, Huang Z, et al. Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy. Transl Lung Cancer Res. 2020;9:2367\u201379. https:\/\/doi.org\/10.21037\/tlcr-20-1130.","journal-title":"Transl Lung Cancer Res"},{"key":"2267_CR16","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1158\/1078-0432.ccr-16-2520","volume":"23","author":"MY Teo","year":"2017","unstructured":"Teo MY, Bambury RM, Zabor EC, et al. DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma. Clin Cancer Res. 2017;23:3610\u20138. https:\/\/doi.org\/10.1158\/1078-0432.ccr-16-2520.","journal-title":"Clin Cancer Res"},{"key":"2267_CR17","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1158\/2159-8290.cd-14-0623","volume":"4","author":"EM Van Allen","year":"2014","unstructured":"Van Allen EM, Mouw KW, Kim P, et al. Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer Discov. 2014;4:1140\u201353. https:\/\/doi.org\/10.1158\/2159-8290.cd-14-0623.","journal-title":"Cancer Discov"},{"key":"2267_CR18","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.1158\/1078-0432.ccr-20-1788","volume":"26","author":"S Yadav","year":"2020","unstructured":"Yadav S, Kasi PM, Bamlet WR, et al. Effect of Germline mutations in homologous recombination repair genes on overall survival of patients with pancreatic adenocarcinoma. Clin Cancer Res. 2020;26:6505\u201312. https:\/\/doi.org\/10.1158\/1078-0432.ccr-20-1788.","journal-title":"Clin Cancer Res"},{"key":"2267_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-024-01542-1","author":"H Ichikawa","year":"2024","unstructured":"Ichikawa H, Aizawa M, Kano Y, et al. Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy. Gastric Cancer. 2024. https:\/\/doi.org\/10.1007\/s10120-024-01542-1.","journal-title":"Gastric Cancer"},{"key":"2267_CR20","doi-asserted-by":"publisher","DOI":"10.1200\/po.23.00195","volume":"7","author":"C Shao","year":"2023","unstructured":"Shao C, Ren Y, Zhou H, et al. Association between homologous recombination repair biomarkers and survival in patients with solid tumors. JCO Precis Oncol. 2023;7: e2300195. https:\/\/doi.org\/10.1200\/po.23.00195.","journal-title":"JCO Precis Oncol"},{"key":"2267_CR21","doi-asserted-by":"crossref","unstructured":"Jeggo PA, Pearl LH, Carr AM. DNA repair, genome stability and cancer: a historical perspective. In: Nat Rev Cancer. England: 2016. pp. 35\u201342.","DOI":"10.1038\/nrc.2015.4"},{"key":"2267_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.euo.2023.12.003","volume":"7","author":"O Cussenot","year":"2024","unstructured":"Cussenot O, Timms KM, Perrot E, et al. Tumour-based mutational profiles predict visceral metastasis outcome and early death in prostate cancer patients. Eur Urol Oncol. 2024;7:597\u2013604. https:\/\/doi.org\/10.1016\/j.euo.2023.12.003.","journal-title":"Eur Urol Oncol"},{"key":"2267_CR23","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1007\/s10120-021-01207-3","volume":"24","author":"Z Li","year":"2021","unstructured":"Li Z, Jia Y, Zhu H, et al. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy. Gastric Cancer. 2021;24:1342\u201354. https:\/\/doi.org\/10.1007\/s10120-021-01207-3.","journal-title":"Gastric Cancer"},{"key":"2267_CR24","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/jco.2012.43.1882","volume":"31","author":"E Castro","year":"2013","unstructured":"Castro E, Goh C, Olmos D, et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol. 2013;31:1748\u201357. https:\/\/doi.org\/10.1200\/jco.2012.43.1882.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02267-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-025-02267-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02267-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:01:52Z","timestamp":1758438112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-025-02267-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2267"],"URL":"https:\/\/doi.org\/10.1007\/s00535-025-02267-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All individuals registered with the portal provided written informed consent for secondary utilization of their clinical records and CGP outcomes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}